Ascensia secures CE Mark for Contour Next One and Contour Plus One blood glucose monitoring systems

17 May 2016 (Last Updated May 17th, 2016 18:30)

US-based specialist diabetes care company, Ascensia, has secured the CE Mark for its new Contour Next One and Contour Plus One blood glucose monitoring systems to assist in the self-monitoring of blood glucose for people with diabetes.

Blood glucose

US-based specialist diabetes care company, Ascensia, has secured the CE Mark for its new Contour Next One and Contour Plus One blood glucose monitoring systems to assist in the self-monitoring of blood glucose for people with diabetes.

The devices are fitted with an easy-to-use wireless-enabled blood glucose smart meter that is connected to a smart mobile device via bluetooth connectivity.

The meter then connects to the Contour Diabetes application, a mobile application that collects, stores and analyses patient blood glucose measurements received from the meter.

The system also includes a smart light on the meter that issues instant feedback on blood glucose results, reminders and alerts to help support better management of diabetes, and features a comprehensive electronic logbook that records events such as meals, activities and medication.

Users can create an optional cloud account for management and storage of data and can email PDF summary reports to their healthcare professionals for discussion.

It is exploring options to bring in new features to help people with diabetes manage their condition.

Blood glucose results can be assessed to determine patterns and trends that may help patients to understand how blood glucose affects their daily activities.

Ascensia Diabetes Care CEO Michael Kloss said: "We believe that the Contour Next One and Contour Plus One blood glucose monitoring systems can be a significant advance for people with diabetes.

"These systems combine the remarkable accuracy of our Contour Next and Contour Plus meter platforms with the easy-to-use features of the Contour Diabetes app to provide insights that help patients to better manage their condition.

"Blood glucose results can be assessed to determine patterns and trends that may help patients to understand how blood glucose affects their daily activities."

"These systems enable people with diabetes to learn more about their condition and make the appropriate management decisions."

Both Contour Next One and Contour Plus One blood glucose monitoring systems have exhibited accuracy that had exceeded the ISO 15197:2013 accuracy criteria in the laboratory and clinical setting.

The devices will initially be introduced in two European markets and later across further European countries in this year.

The Contour Diabetes application will be made available in the Apple App Store (iOS) and Google Play (Android).


Image: The process of blood glucose testing. Photo: courtesy of David-i98.